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ABSTRACT 
  
The basalo-cortical cholinergic innervation reaches neural targets in cortex cerebri where it modulates the 
incoming sensory information, regulating arousal, attention, vigilance, memory and cognition. Progressive de-
generation of the cholinergic neurons in the basal forebrain is considered a hallmark of Alzheimer’s disease re-
lated to cognitive impairment in this condition. Dysregulation of cholinergic neurotransmission has also been 
implicated in schizophrenia, a chronic and debilitating neurodevelopmental disorder characterized by positive 
and negative symptoms and cognitive impairments, with deficits in thought processes, perceptions and emo-
tional responsiveness. Modeling specific disruption of cholinergic function allows studies of its behavioral and 
molecular consequences and may contribute to the development of future therapies for Alzheimer’s disease and 
Schizophrenia.  
 To investigate the role of the cholinergic system, we carried out uni- and bilateral cholinergic denervation 
of cortex cerebri in male Lister hooded rats using the selective immunotoxin 192 IgG-saporin to specifically 
target the cholinergic neurons of nucleus basalis of magnocellularis (NBM). IgG-saporin effectively removed 
cholinergic afferents to the cortical mantle. Intact and denervated rats were challenged with phencyclidine 
(PCP), a non-competitive NMDA receptor antagonist, which is known to produce schizophrenia-like psychosis 
in humans and hence used to model aspects of schizophrenia in rats. Experiments were conducted to determine 
the effects on behavior and to shed light on the underlying molecular mechanisms.  
 Negative symptoms of schizophrenia include social withdrawal, which is studied in animal models using 
social interaction tests. We found that cortical cholinergic denervation lead to a significant reduction in the 
duration of active social interaction in pairs of lesioned animals versus pairs of sham-operated controls. After an 
acute dose low of PCP (1 mg/kg, s.c.), there was a marked decrease in active social interaction for both groups, 
such that there was no longer a difference between lesioned and control animals. To evaluate cognitive 
impairments, particularly those reflecting declarative memory, a novel object recognition test was used. Neither 
cholinergic denervation alone, nor an acute PCP dose (1 mg/kg, s.c.) alone, blocked the ability of rats to 
recognize a novel object. However, animals lacking cortical cholinergic innervation and challenged with PCP 
were no longer able to recognize the novel object (Paper I). 
    Behavioral paradigms have typically been analyzed manually, though automated hardware and software 
systems have been introduced to speed up the process and eliminate subjective errors. However, the reliability 
and accuracy of computerized scoring needs to be verified for each specific paradigm. For novel object 
recognition, the program scoring reduced analysis time for the task, but needed manual corrections to avoid 
erroneous data points. Manual for scoring of social interaction revealed that this labor intensive approach was 
more nuanced and allowed to discern complex behaviors, whereas the automated scoring system registered 
more global interaction patterns. It is concluded that manual and computerized techniques for scoring social 
interaction offer complimentary information on various aspects of this complex behavioral task (Paper II).  
 The next studies were aimed to examine the bases of the behavioral responses to cortical cholinergic 
denervation and PCP challenge at the molecular level. PCP-induced neuronal activation was mapped using 
quantitative in situ hybridization of the neuronal immediate early gene c-Fos mRNA levels. Transcription of c-
Fos responds to many different forms of activation, including stress and toxins. We found that two doses of PCP 
used (2 and 3 mg/kg, s.c.) caused a marked increase in neuronal c-Fos mRNA expression at 30 and 60 min after 
PCP administration, though these doses did not alter the levels of BDNF or Nogo receptor mRNA. Importantly, 
PCP responses were markedly dampened in cholinergically denervated regions of cortex cerebri (Paper III).   
   RNA-Sequencing was then employed to understand gene regulatory processes at a global level in 
somatosensory cortex with regard to effects of chronic denervation and/or a PCP challenge (1 and 3 mg/kg, 
s.c.). A first round of analysis focused on the genes most significantly altered by denervation (Egr1, Dusp6, 
Ier2, Nr4a1), PCP treatment (Cyr61, Bcl6b, Apold1, Dusp1) and those altered over time (Sox9, Coq10b, 
Zfp189, Rnf39) (Paper IV). The most common response was for mRNA levels to increase in response to PCP 
and for cholinergic denervation to dampen these increases.  
 The findings presented in this thesis support a role for the cholinergic system in assigning significance to 
incoming stimuli as exemplified by regulating the response of cortical neurons to a PCP challenge. The findings 
are also compatible with a proposed involvement of cholinergic dysfunction in schizophrenia.  
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